FindRx, a Boston-based healthcare startup, has been selected as one of the Top 3 Alternates in the Student Startup category for the 2025 SXSW Pitch competition. This recognition underscores the company's innovative approach to addressing critical medication shortages.
FindRx focuses on tackling shortages of essential medications, including treatments for ADHD and diabetic injections. By leveraging deep clinical expertise and innovative strategies, the company aims to provide reliable support to both patients and healthcare institutions. Additionally, FindRx is expanding into data services, offering real-time pharmacy inventory analytics to enable strategic, data-driven decisions within the healthcare sector.
The SXSW Pitch competition serves as a platform for early-stage technology startups to present their products and services to industry experts, media professionals, and investors. The Student Startup category highlights emerging companies that are introducing groundbreaking technologies across various sectors.
While FindRx's designation as an alternate means they may not present unless a finalist is unable to participate, this acknowledgment reflects the company's potential and the significance of their mission. Their inclusion in the SXSW Pitch lineup brings attention to the pressing issue of medication shortages and the innovative solutions being developed to address these challenges.
The SXSW Pitch event took place from March 8–10, 2025, in Austin, Texas, during the broader SXSW Conference & Festivals. This annual event showcases some of the global startup ecosystem's most exciting and cutting-edge technologies, providing companies like FindRx with valuable exposure and networking opportunities.
FindRx's recognition at SXSW highlights the critical need for innovative solutions in healthcare and emphasizes the company's commitment to improving patient outcomes through technology and data-driven strategies.
Jay Choi
Northeastern University, PharmD Candidate
2025/03/12
Comments